STOCK TITAN

Evolent Health, Inc - EVH STOCK NEWS

Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.

Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.

Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.

The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.

Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.

In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.

Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) reported strong financial results for Q4 and FY 2023, with revenue increasing over 45%, net loss margin at (7.2)%, and adjusted EBITDA margin at 9.9%. The CEO highlighted successful integration of NIA and new revenue agreements for 2024, projecting revenue growth of 25% at the midpoint. Evolent's financial position is robust, with cash flow exceeding targets and improved balance sheet flexibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.44%
Tags
-
Rhea-AI Summary
Evolent Health, Inc. appoints Russell Glass to its Board of Directors, replacing Dr. Tunde Sotunde. Glass brings extensive experience in technology and health care. The company aims to continue its innovative leadership in the value-based specialty care market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
management
-
Rhea-AI Summary
Evolent Health, Inc. (EVH) will release its fourth quarter 2023 financial results on Thursday, Feb. 22, 2024, after market close. The company will also participate in upcoming investor conferences including Cowen 44th Annual Health Care Conference, Jefferies Annual Value-Based Healthcare Summit, Barclays 26th Annual Global Healthcare Conference, and Oppenheimer 34th Annual Healthcare MedTech & Services Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) announced the pricing of $350.0 million aggregate principal amount of 3.50% convertible senior notes due 2029. The notes are being offered to qualified institutional buyers and are convertible into cash, shares of Evolent's Class A common stock, or a combination of both. The initial conversion price represents a premium of approximately 42.50% over the closing price of the Class A common stock on December 5, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
none
-
Rhea-AI Summary
Evolent Health, Inc. (NYSE: EVH) plans to offer $350.0 million aggregate principal amount of convertible senior notes due 2029, with an option for additional $52.5 million aggregate principal amount of notes. The net proceeds will be used to prepay outstanding borrowings and pay related fees under its term loan facility, which matures in January 2029.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.1%
Tags
none
-
Rhea-AI Summary
Evolent Health, Inc. announced financial results for Q3 2023, with revenue of $511.0 million, a 44.9% increase compared to Q3 2022. The net loss attributable to common shareholders was $33.2 million, resulting in a net loss margin of (6.5)%. Evolent added three new operating partnerships and signed an important cross-sell agreement. The company raised the mid-point of its outlook for revenue and Adjusted EBITDA in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.54%
Tags
Rhea-AI Summary
Evolent Health to release Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
conferences earnings
-
Rhea-AI Summary
Evolent Health's ACO saved Medicare over $55 million in 2022, ranking in the top 2% of ACOs. The ACO improved quality and reduced costs by 5.6%. Evolent's Performance Suite partnership with Humana in North Florida to launch on September 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
conferences
Rhea-AI Summary
Evolent Health, Inc. announces Q2 2023 financial results with revenue of $469.1 million, an increase of 46.6% compared to the same period last year. Net loss margin was (8.8%) and Adjusted EBITDA margin was 10.1%. Total Lives on Platform increased to 78.6 million. The company signed new operating partnerships and expansions, showing strong business momentum. CEO Seth Blackley raises Adjusted EBITDA range for 2023 and expresses confidence in the company's medium-term target of $300 million in Adjusted EBITDA run-rate exiting 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags

FAQ

What is the current stock price of Evolent Health (EVH)?

The current stock price of Evolent Health (EVH) is $11.41 as of December 20, 2024.

What is the market cap of Evolent Health (EVH)?

The market cap of Evolent Health (EVH) is approximately 1.3B.

What is the primary business of Evolent Health, Inc.?

Evolent Health, Inc. supports health systems and physician organizations in transitioning to value-based care and population health management.

Where is Evolent Health headquartered?

Evolent Health is headquartered in Arlington, Virginia.

What recent financial achievements has Evolent Health reported?

Evolent Health exceeded profitability expectations in Q3 2023 and reported $184.5 million in cash and cash equivalents as of September 30, 2023.

What are some of the core services provided by Evolent Health?

Evolent Health provides specialty care management, total cost of care management, and health plan administration services.

What recent acquisition did Evolent Health announce?

Evolent Health announced the acquisition of Machinify Auth, an AI-powered software platform for clinical reviews.

Who are some of the backers of Evolent Health?

Evolent Health is backed by The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth.

What are the primary specialty care areas Evolent focuses on?

Evolent focuses on oncology, cardiology, and musculoskeletal care.

How does Evolent Health view its company culture?

Evolent Health promotes a collaborative and innovative work environment with benefits like treadmill desks and wellness challenges.

What is the significance of Evolent’s acquisition of Machinify Auth?

The acquisition is expected to enhance Evolent’s capabilities in AI-driven healthcare, improving the efficiency of clinical reviews.

How has Evolent Health performed financially in recent quarters?

Evolent Health has reported strong financial performance, with increased profitability, new partnerships, and a solid financial outlook for the year.

Evolent Health, Inc

NYSE:EVH

EVH Rankings

EVH Stock Data

1.29B
112.49M
3.95%
115.81%
9.41%
Health Information Services
Services-management Services
Link
United States of America
ARLINGTON